CDKN2B-AS1 and angina pectoris: The ROC analysis showed that ANRIL in plasma provided a more accurate diagnostic rate in the stable angina stage, suggesting that ANRIL in plasma may be more sensitive and specific for the diagnosis of early coronary heart disease.